HEADER OXIDOREDUCTASE 30-MAR-07 2UXW TITLE CRYSTAL STRUCTURE OF HUMAN VERY LONG CHAIN ACYL-COA DEHYDROGENASE TITLE 2 (ACADVL) COMPND MOL_ID: 1; COMPND 2 MOLECULE: VERY-LONG-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 72-655; COMPND 5 SYNONYM: VLCAD, ACYL-COA DEHYDROGENASE; COMPND 6 EC: 1.3.99.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: R3-PRARE2; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS FATTY ACID METABOLISM, TRANSIT PEPTIDE, DISEASE MUTATION, LIPID KEYWDS 2 METABOLISM, COENZYME A DEHYDROGENASE, VERY LONG CHAIN FATTY ACIDS, KEYWDS 3 FAD, FLAVOPROTEIN, MITOCHONDRIAL FATTY ACID BETA-OXIDATION, KEYWDS 4 MITOCHONDRION, OXIDOREDUCTASE, CARDIOMYOPATHY EXPDTA X-RAY DIFFRACTION AUTHOR A.C.W.PIKE,V.HOZJAN,C.SMEE,G.BERRIDGE,N.BURGESS,E.SALAH,G.BUNKOCZI, AUTHOR 2 J.UPPENBERG,E.UGOCHUKWU,F.VON DELFT,C.H.ARROWSMITH,A.EDWARDS, AUTHOR 3 J.WEIGELT,M.SUNDSTROM,U.OPPERMANN REVDAT 5 13-DEC-23 2UXW 1 REMARK REVDAT 4 24-JAN-18 2UXW 1 AUTHOR JRNL REVDAT 3 13-JUL-11 2UXW 1 VERSN REVDAT 2 24-FEB-09 2UXW 1 VERSN REVDAT 1 01-MAY-07 2UXW 0 JRNL AUTH A.C.W.PIKE,V.HOZJAN,C.SMEE,G.BERRIDGE,N.BURGESS,E.SALAH, JRNL AUTH 2 G.BUNKOCZI,J.UPPENBERG,E.UGOCHUKWU,F.VON DELFT, JRNL AUTH 3 C.H.ARROWSMITH,A.EDWARDS,J.WEIGELT,M.SUNDSTROM,U.OPPERMANN JRNL TITL CRYSTAL STRUCTURE OF HUMAN VERY LONG CHAIN ACYL- COA JRNL TITL 2 DEHYDROGENASE (ACADVL) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 102266 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.170 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5352 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7551 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE SET COUNT : 362 REMARK 3 BIN FREE R VALUE : 0.2680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4275 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 85 REMARK 3 SOLVENT ATOMS : 504 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 16.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70000 REMARK 3 B22 (A**2) : -0.31000 REMARK 3 B33 (A**2) : -0.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.053 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.055 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.037 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.874 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.977 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.968 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4545 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3107 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6137 ; 1.330 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7532 ; 0.798 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 565 ; 5.082 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 185 ;36.915 ;23.892 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 794 ;11.757 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;14.892 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 698 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4976 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 903 ; 0.000 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 978 ; 0.228 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3208 ; 0.200 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2296 ; 0.190 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 2255 ; 0.094 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 657 ; 0.181 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 11 ; 0.145 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 100 ; 0.313 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 72 ; 0.176 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2873 ; 2.060 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4529 ; 2.923 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1866 ; 4.363 ; 7.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1608 ; 6.803 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -2 A 655 REMARK 3 ORIGIN FOR THE GROUP (A): 9.6296 23.8312 22.2142 REMARK 3 T TENSOR REMARK 3 T11: -0.0473 T22: -0.0551 REMARK 3 T33: -0.0682 T12: -0.0038 REMARK 3 T13: 0.0087 T23: 0.0023 REMARK 3 L TENSOR REMARK 3 L11: 0.5529 L22: 0.4185 REMARK 3 L33: 0.4374 L12: 0.0168 REMARK 3 L13: -0.0102 L23: 0.0316 REMARK 3 S TENSOR REMARK 3 S11: -0.0100 S12: 0.1012 S13: -0.0222 REMARK 3 S21: -0.1226 S22: 0.0001 S23: -0.0422 REMARK 3 S31: -0.0201 S32: 0.0395 S33: 0.0099 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DENSITY IN THE ACTIVE SITE HAS BEEN MODELLED AS A REMARK 3 PARTIALLY ORDERED TRANS DELTA2 PALMITENOYL COENZYME A MOLECULE. REMARK 3 THIS ENZYME PRODUCT PRESUMABLY COPURIFIED WITH THE BACTERIALLY REMARK 3 EXPRESSED ENZYME. REMARK 4 REMARK 4 2UXW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1290032142. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9182 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 107669 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 47.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.78000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2JIF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG3350, 0.1M SODIUM SUCCINATE REMARK 280 PH7.0, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.86550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.86550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.50050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.08650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.50050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.08650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 74.86550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.50050 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 54.08650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 74.86550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.50050 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 54.08650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 74.86550 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2347 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 SER A -15 REMARK 465 SER A -14 REMARK 465 GLY A -13 REMARK 465 VAL A -12 REMARK 465 ASP A -11 REMARK 465 LEU A -10 REMARK 465 GLY A -9 REMARK 465 THR A -8 REMARK 465 GLU A -7 REMARK 465 ASN A -6 REMARK 465 LEU A -5 REMARK 465 TYR A -4 REMARK 465 PHE A -3 REMARK 465 ASN A 497 REMARK 465 ALA A 498 REMARK 465 GLY A 499 REMARK 465 LEU A 500 REMARK 465 LEU A 501 REMARK 465 LEU A 502 REMARK 465 GLY A 503 REMARK 465 GLU A 504 REMARK 465 ALA A 505 REMARK 465 GLY A 506 REMARK 465 LYS A 507 REMARK 465 GLN A 508 REMARK 465 LEU A 509 REMARK 465 ARG A 510 REMARK 465 ARG A 511 REMARK 465 ARG A 512 REMARK 465 ALA A 513 REMARK 465 GLY A 514 REMARK 465 LEU A 515 REMARK 465 GLY A 516 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A -2 CG CD OE1 NE2 REMARK 470 GLU A 96 CD OE1 OE2 REMARK 470 LYS A 239 CG CD CE NZ REMARK 470 LYS A 276 CD CE NZ REMARK 470 GLU A 325 CD OE1 OE2 REMARK 470 LYS A 331 CD CE NZ REMARK 470 LYS A 444 CE NZ REMARK 470 GLU A 445 CD OE1 OE2 REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 LYS A 553 NZ REMARK 470 LYS A 556 NZ REMARK 470 LYS A 639 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 169 CG - SD - CE ANGL. DEV. = -10.7 DEGREES REMARK 500 MET A 300 CG - SD - CE ANGL. DEV. = -11.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 171 95.47 -163.36 REMARK 500 ILE A 184 -30.68 -130.90 REMARK 500 ILE A 302 46.35 34.06 REMARK 500 LYS A 555 -137.78 48.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 TH3 A 750 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 680 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 681 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH3 A 750 DBREF 2UXW A -22 0 PDB 2UXW 2UXW -22 0 DBREF 2UXW A 72 655 UNP P49748 ACADV_HUMAN 72 655 SEQRES 1 A 607 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 607 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER PHE ALA SEQRES 3 A 607 VAL GLY MET PHE LYS GLY GLN LEU THR THR ASP GLN VAL SEQRES 4 A 607 PHE PRO TYR PRO SER VAL LEU ASN GLU GLU GLN THR GLN SEQRES 5 A 607 PHE LEU LYS GLU LEU VAL GLU PRO VAL SER ARG PHE PHE SEQRES 6 A 607 GLU GLU VAL ASN ASP PRO ALA LYS ASN ASP ALA LEU GLU SEQRES 7 A 607 MET VAL GLU GLU THR THR TRP GLN GLY LEU LYS GLU LEU SEQRES 8 A 607 GLY ALA PHE GLY LEU GLN VAL PRO SER GLU LEU GLY GLY SEQRES 9 A 607 VAL GLY LEU CYS ASN THR GLN TYR ALA ARG LEU VAL GLU SEQRES 10 A 607 ILE VAL GLY MET HIS ASP LEU GLY VAL GLY ILE THR LEU SEQRES 11 A 607 GLY ALA HIS GLN SER ILE GLY PHE LYS GLY ILE LEU LEU SEQRES 12 A 607 PHE GLY THR LYS ALA GLN LYS GLU LYS TYR LEU PRO LYS SEQRES 13 A 607 LEU ALA SER GLY GLU THR VAL ALA ALA PHE CYS LEU THR SEQRES 14 A 607 GLU PRO SER SER GLY SER ASP ALA ALA SER ILE ARG THR SEQRES 15 A 607 SER ALA VAL PRO SER PRO CYS GLY LYS TYR TYR THR LEU SEQRES 16 A 607 ASN GLY SER LYS LEU TRP ILE SER ASN GLY GLY LEU ALA SEQRES 17 A 607 ASP ILE PHE THR VAL PHE ALA LYS THR PRO VAL THR ASP SEQRES 18 A 607 PRO ALA THR GLY ALA VAL LYS GLU LYS ILE THR ALA PHE SEQRES 19 A 607 VAL VAL GLU ARG GLY PHE GLY GLY ILE THR HIS GLY PRO SEQRES 20 A 607 PRO GLU LYS LYS MET GLY ILE LYS ALA SER ASN THR ALA SEQRES 21 A 607 GLU VAL PHE PHE ASP GLY VAL ARG VAL PRO SER GLU ASN SEQRES 22 A 607 VAL LEU GLY GLU VAL GLY SER GLY PHE LYS VAL ALA MET SEQRES 23 A 607 HIS ILE LEU ASN ASN GLY ARG PHE GLY MET ALA ALA ALA SEQRES 24 A 607 LEU ALA GLY THR MET ARG GLY ILE ILE ALA LYS ALA VAL SEQRES 25 A 607 ASP HIS ALA THR ASN ARG THR GLN PHE GLY GLU LYS ILE SEQRES 26 A 607 HIS ASN PHE GLY LEU ILE GLN GLU LYS LEU ALA ARG MET SEQRES 27 A 607 VAL MET LEU GLN TYR VAL THR GLU SER MET ALA TYR MET SEQRES 28 A 607 VAL SER ALA ASN MET ASP GLN GLY ALA THR ASP PHE GLN SEQRES 29 A 607 ILE GLU ALA ALA ILE SER LYS ILE PHE GLY SER GLU ALA SEQRES 30 A 607 ALA TRP LYS VAL THR ASP GLU CYS ILE GLN ILE MET GLY SEQRES 31 A 607 GLY MET GLY PHE MET LYS GLU PRO GLY VAL GLU ARG VAL SEQRES 32 A 607 LEU ARG ASP LEU ARG ILE PHE ARG ILE PHE GLU GLY THR SEQRES 33 A 607 ASN ASP ILE LEU ARG LEU PHE VAL ALA LEU GLN GLY CYS SEQRES 34 A 607 MET ASP LYS GLY LYS GLU LEU SER GLY LEU GLY SER ALA SEQRES 35 A 607 LEU LYS ASN PRO PHE GLY ASN ALA GLY LEU LEU LEU GLY SEQRES 36 A 607 GLU ALA GLY LYS GLN LEU ARG ARG ARG ALA GLY LEU GLY SEQRES 37 A 607 SER GLY LEU SER LEU SER GLY LEU VAL HIS PRO GLU LEU SEQRES 38 A 607 SER ARG SER GLY GLU LEU ALA VAL ARG ALA LEU GLU GLN SEQRES 39 A 607 PHE ALA THR VAL VAL GLU ALA LYS LEU ILE LYS HIS LYS SEQRES 40 A 607 LYS GLY ILE VAL ASN GLU GLN PHE LEU LEU GLN ARG LEU SEQRES 41 A 607 ALA ASP GLY ALA ILE ASP LEU TYR ALA MET VAL VAL VAL SEQRES 42 A 607 LEU SER ARG ALA SER ARG SER LEU SER GLU GLY HIS PRO SEQRES 43 A 607 THR ALA GLN HIS GLU LYS MET LEU CYS ASP THR TRP CYS SEQRES 44 A 607 ILE GLU ALA ALA ALA ARG ILE ARG GLU GLY MET ALA ALA SEQRES 45 A 607 LEU GLN SER ASP PRO TRP GLN GLN GLU LEU TYR ARG ASN SEQRES 46 A 607 PHE LYS SER ILE SER LYS ALA LEU VAL GLU ARG GLY GLY SEQRES 47 A 607 VAL VAL THR SER ASN PRO LEU GLY PHE HET EDO A 680 4 HET EDO A 681 4 HET FAD A 700 53 HET TH3 A 750 24 HETNAM EDO 1,2-ETHANEDIOL HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM TH3 TRANS DELTA2 PALMITENOYL-COENZYMEA HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO 2(C2 H6 O2) FORMUL 4 FAD C27 H33 N9 O15 P2 FORMUL 5 TH3 C37 H64 N7 O17 P3 S FORMUL 6 HOH *504(H2 O) HELIX 1 1 SER A 72 PHE A 78 1 7 HELIX 2 2 ASN A 95 VAL A 116 1 22 HELIX 3 3 ASP A 118 GLU A 126 1 9 HELIX 4 4 GLU A 129 LEU A 139 1 11 HELIX 5 5 PRO A 147 GLY A 151 5 5 HELIX 6 6 CYS A 156 ASP A 171 1 16 HELIX 7 7 ASP A 171 SER A 183 1 13 HELIX 8 8 PHE A 186 GLY A 193 1 8 HELIX 9 9 THR A 194 SER A 207 1 14 HELIX 10 10 ASP A 224 ILE A 228 5 5 HELIX 11 11 GLY A 287 GLY A 289 5 3 HELIX 12 12 SER A 328 ARG A 366 1 39 HELIX 13 13 PHE A 376 GLN A 406 1 31 HELIX 14 14 PHE A 411 GLY A 438 1 28 HELIX 15 15 GLY A 438 MET A 443 1 6 HELIX 16 16 GLY A 447 ARG A 456 1 10 HELIX 17 17 ILE A 457 ILE A 460 5 4 HELIX 18 18 THR A 464 GLY A 486 1 23 HELIX 19 19 LEU A 487 SER A 489 5 3 HELIX 20 20 HIS A 526 GLU A 528 5 3 HELIX 21 21 LEU A 529 LYS A 555 1 27 HELIX 22 22 LYS A 556 ASN A 560 5 5 HELIX 23 23 GLU A 561 GLY A 592 1 32 HELIX 24 24 THR A 595 SER A 623 1 29 HELIX 25 25 TRP A 626 GLY A 645 1 20 SHEET 1 AA 4 ALA A 212 CYS A 215 0 SHEET 2 AA 4 ILE A 258 THR A 268 1 O ILE A 258 N ALA A 213 SHEET 3 AA 4 VAL A 275 GLU A 285 -1 O LYS A 276 N VAL A 267 SHEET 4 AA 4 VAL A 322 LEU A 323 -1 O LEU A 323 N ALA A 281 SHEET 1 AB 4 SER A 231 PRO A 234 0 SHEET 2 AB 4 TYR A 240 SER A 251 -1 O THR A 242 N VAL A 233 SHEET 3 AB 4 THR A 307 PRO A 318 -1 O ALA A 308 N ILE A 250 SHEET 4 AB 4 ILE A 291 HIS A 293 -1 O THR A 292 N PHE A 311 SHEET 1 AC 2 THR A 367 GLN A 368 0 SHEET 2 AC 2 GLU A 371 LYS A 372 -1 O GLU A 371 N GLN A 368 CISPEP 1 PHE A 88 PRO A 89 0 -5.72 SITE 1 AC1 7 PHE A 376 PRO A 494 PHE A 495 GLN A 562 SITE 2 AC1 7 FAD A 700 HOH A2405 HOH A2407 SITE 1 AC2 4 GLY A 254 LEU A 255 ASP A 257 ARG A 286 SITE 1 AC3 30 PHE A 214 LEU A 216 THR A 217 GLY A 222 SITE 2 AC3 30 SER A 223 TRP A 249 ILE A 250 SER A 251 SITE 3 AC3 30 ARG A 366 GLN A 368 PHE A 369 ILE A 373 SITE 4 AC3 30 PHE A 376 GLN A 435 ILE A 436 GLY A 439 SITE 5 AC3 30 MET A 443 ILE A 457 PHE A 461 THR A 464 SITE 6 AC3 30 ASP A 466 ILE A 467 GLN A 562 EDO A 680 SITE 7 AC3 30 TH3 A 750 HOH A2297 HOH A2352 HOH A2502 SITE 8 AC3 30 HOH A2503 HOH A2504 SITE 1 AC4 11 TYR A 160 GLY A 175 ILE A 184 PHE A 214 SITE 2 AC4 11 GLY A 222 LEU A 337 PHE A 461 GLU A 462 SITE 3 AC4 11 GLY A 463 FAD A 700 HOH A2171 CRYST1 75.001 108.173 149.731 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013333 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009244 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006679 0.00000